🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

Recruitingn/aAges any - anyAllUniversity of Pennsylvania
NCT00315380 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of this disease in people with EGPA.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Patients with a diagnosis of eosinophilic granulomatosis with polyangiitis are eligible for the study. Parent or guardian willing to provide informed consent, if applicable Exclusion Criteria: \- Inability to give informed consent and to sign the consent form
💊

What it tests

  • Not listed
📍

Where

15 sites
University of California San Diego
San Diego, United States
National Jewish Health
Denver, United States
Brigham and Women's Hospital
Boston, United States
Mayo Clinic
Rochester, United States
Cleveland Clinic Foundation
Cleveland, United States
University of Pennsylvania
Philadelphia, United States
University of Pittsburgh
Pittsburgh, United States
University of Utah
Salt Lake City, United States

…and 7 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy